Anti Cathepsin B Market
According to Intent Market Research, the Anti-Cathepsin B Market is expected to grow from USD 0.6 Billion in 2024-e at a CAGR of 9.6% to touch USD 1.2 Billion by 2030. The Anti-Cathepsin B Market is dominated by key players such as, Novartis, Roche, Merck, Pfizer, Bayer, and AbbVie.